Pinnacle Associates LTD Becton Dickinson & CO Transaction History

Pinnacle Associates LTD

$6.3 Billion
Q3 2024

A detailed history of Pinnacle Associates LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Pinnacle Associates LTD holds 33,738 shares of BDX stock, worth $7.71 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

33,738

Previous 33,518 0.66%

Holding current value

$7.71 Million

Previous $7.83 Million 3.84%

% of portfolio

0.13%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$221.47 - $242.41 $48,723 - $53,330	220 Added 0.66%	33,738 $8.13 Million
Q2 2024 Jul 30, 2024	BUY	$225.07 - $246.17 $38,261 - $41,848	170 Added 0.51%	33,518 $7.83 Million
Q1 2024 Apr 26, 2024	SELL	$233.45 - $247.73 $91,045 - $96,614	-390 Reduced 1.16%	33,348 $8.25 Million
Q4 2023 Jan 19, 2024	BUY	$232.24 - $267.23 $237,581 - $273,376	1,023 Added 3.13%	33,738 $8.23 Million
Q3 2023 Oct 23, 2023	BUY	$254.9 - $283.59 $88,960 - $98,972	349 Added 1.08%	32,715 $8.46 Million
Q2 2023 Jul 26, 2023	BUY	$238.39 - $265.32 $2.96 Million - $3.29 Million	12,403 Added 62.13%	32,366 $8.54 Million
Q1 2023 May 04, 2023	BUY	$229.71 - $259.35 $498,011 - $562,270	2,168 Added 12.18%	19,963 $4.94 Million
Q4 2022 Jan 31, 2023	BUY	$218.29 - $256.91 $654 - $770	3 Added 0.02%	17,795 $4.53 Million
Q4 2022 Jan 25, 2023	BUY	$218.29 - $256.91 $379,824 - $447,023	1,740 Added 10.84%	17,792 $0
Q3 2022 Oct 31, 2022	SELL	$51.03 - $264.23 $52,918 - $274,006	-1,037 Reduced 6.07%	16,052 $3.58 Million
Q2 2022 Aug 02, 2022	BUY	$234.74 - $275.42 $39,436 - $46,270	168 Added 0.99%	17,089 $4.21 Million
Q1 2022 May 05, 2022	SELL	$243.64 - $270.48 $336,954 - $374,073	-1,383 Reduced 7.56%	16,921 $4.5 Million
Q4 2021 Feb 02, 2022	SELL	$230.08 - $250.94 $852,906 - $930,234	-3,707 Reduced 16.84%	18,304 $4.6 Million
Q3 2021 Oct 19, 2021	SELL	$232.72 - $256.47 $14,894 - $16,414	-64 Reduced 0.29%	22,011 $5.41 Million
Q2 2021 Aug 02, 2021	BUY	$232.65 - $254.58 $64,211 - $70,264	276 Added 1.27%	22,075 $5.37 Million
Q1 2021 May 12, 2021	BUY	$232.09 - $256.88 $161,998 - $179,302	698 Added 3.31%	21,799 $5.3 Million
Q4 2020 Jan 26, 2021	BUY	$221.92 - $245.94 $24,633 - $27,299	111 Added 0.53%	21,101 $5.28 Million
Q3 2020 Oct 23, 2020	SELL	$215.77 - $276.76 $33,444 - $42,897	-155 Reduced 0.73%	20,990 $4.88 Million
Q2 2020 Aug 14, 2020	SELL	$219.9 - $263.41 $133,479 - $159,889	-607 Reduced 2.79%	21,145 $5.06 Million
Q1 2020 May 13, 2020	SELL	$195.69 - $279.01 $205,670 - $293,239	-1,051 Reduced 4.61%	21,752 $5 Million
Q4 2019 Feb 03, 2020	SELL	$236.45 - $266.82 $196,253 - $221,460	-830 Reduced 3.51%	22,803 $6.2 Million
Q3 2019 Nov 08, 2019	SELL	$230.58 - $256.08 $68,482 - $76,055	-297 Reduced 1.24%	23,633 $5.98 Million
Q2 2019 Aug 05, 2019	SELL	$217.4 - $246.08 $28,262 - $31,990	-130 Reduced 0.54%	23,930 $6.03 Million
Q1 2019 May 10, 2019	SELL	$206.05 - $248.17 $158,658 - $191,090	-770 Reduced 3.1%	24,060 $6.01 Million
Q4 2018 Feb 05, 2019	BUY	$204.73 - $257.93 $27,433 - $34,562	134 Added 0.54%	24,830 $5.6 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $116,535 - $128,000	-500 Reduced 1.98%	24,696 $6.45 Million
Q2 2018 Aug 08, 2018	BUY	$208.1 - $233.85 $51,400 - $57,760	247 Added 0.99%	25,196 $6.04 Million
Q1 2018 May 11, 2018	SELL	$205.46 - $240.27 $493,309 - $576,888	-2,401 Reduced 8.78%	24,949 $5.41 Million
Q4 2017 Feb 12, 2018	BUY	$189.0 - $222.64 $55,377 - $65,233	293 Added 1.08%	27,350 $5.86 Million
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $40,555 - $43,161	217 Added 0.81%	27,057 $5.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	26,840	26,840 $5.24 Million

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.

Account

Pinnacle Associates LTD Becton Dickinson & CO Transaction History